Mathers M J, Lazica D A, Klotz T, Sommer F, Roth S
Urologische Gemeinschaftspraxis, Kooperationspraxis der Klinik für Urologie und Kinderurologie, Klinikum Wuppertal, Universität Witten/Herdecke, Fastenrathstrasse 1, 42853 Remscheid, Germany.
Urologe A. 2007 Jun;46(6):636-41. doi: 10.1007/s00120-007-1353-2.
It is generally agreed upon that patients require a caring as well as careful medical follow-up after cancer treatment. The goal of secondary prevention is to recognize a recurrence at an early stage and to use the curative chance while the tumor mass is still small. There is evidence of a medically effective and successful follow-up for tumors of the testicle and the bladder. For quality reasons, these follow-up regimes should be adhered to for quality reasons. In other diseases, e.g., renal cell carcinoma, prospective randomized studies are missing which demonstrate the effectiveness of follow-ups. In these cases asymptomatic patients should be stratified to individualized follow-up care.
人们普遍认为，癌症治疗后患者需要贴心且细致的医疗随访。二级预防的目标是在早期识别复发情况，并在肿瘤体积尚小时利用治愈的机会。有证据表明，针对睾丸癌和膀胱癌的随访在医学上是有效且成功的。出于质量原因，应坚持这些随访方案。在其他疾病中，例如肾细胞癌，缺乏前瞻性随机研究来证明随访的有效性。在这些情况下，无症状患者应分层接受个体化随访护理。
